Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution.
暂无分享,去创建一个
A. Aiuti | A. Fantoni | L. Simeoni | P. Forte | A. Rufini | T. Moretti
[1] R. Aspinall,et al. Thymic Involution in Aging , 2000, Journal of Clinical Immunology.
[2] A. Fattorossi,et al. Membrane expression of HLA-Cw4 free chains in activated T cells of transgenic mice , 2004, Immunogenetics.
[3] A. Fattorossi,et al. Human CD4 produced in lymphoid cells of transgenic mice binds HIV gp120 and modifies the subsets of mouse T-cell populations , 2004, Immunogenetics.
[4] W. Simmons,et al. Proline specific endo- and exopeptidases , 1980, Molecular and Cellular Biochemistry.
[5] S. Iwata,et al. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] B. Fleischer,et al. Molecular analysis of CD26-mediated signal transduction in T cells. , 2000, Immunology letters.
[7] I. De Meester,et al. CD26, let it cut or cut it down. , 1999, Immunology today.
[8] F. Bolognani,et al. Homeostasis, Thymic Hormones and Aging , 1999, Gerontology.
[9] J. Souberbielle,et al. Growth hormone and its receptor are expressed in human thymic cells. , 1998, Endocrinology.
[10] G. Opdenakker,et al. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. , 1998, Biochemistry.
[11] P. Ruiz,et al. Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. , 1998, Clinical immunology and immunopathology.
[12] J. Klein. Hormone regulation of immune homeostasis: local or long distance? , 1998, Biochemical pharmacology.
[13] T. Honjo,et al. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage , 1998 .
[14] Dominique Schols,et al. Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV , 1998, The Journal of Biological Chemistry.
[15] B. Fleischer,et al. Dipeptidyl‐peptidase IV/CD26 on T cells: analysis of an alternative T‐cell activation pathway , 1998, Immunological reviews.
[16] Chika Morimoto,et al. The structure and function of CD26 in the T‐cell immune response , 1998, Immunological reviews.
[17] M. Hegen,et al. Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. , 1998, Molecular immunology.
[18] M. Ditto,et al. Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage , 1997, The Journal of experimental medicine.
[19] Y. Bar-dayan,et al. Thymic aging in ICR female mice is suspended by prolonged hydrocortisone exposure , 1997, Cell and Tissue Research.
[20] B. Bodey,et al. Involution of the mammalian thymus, one of the leading regulators of aging. , 1997, In vivo.
[21] H. Mittrücker,et al. The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling. , 1997, Immunology letters.
[22] M. Nagarkatti,et al. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. , 1997, Toxicology and applied pharmacology.
[23] C. Abbott,et al. Molecular analyses of human and rat dipeptidyl peptidase IV. , 1997, Advances in experimental medicine and biology.
[24] M. Hegen,et al. Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. , 1997, Advances in experimental medicine and biology.
[25] U. Lendeckel,et al. CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. , 1997, Advances in experimental medicine and biology.
[26] M. Ritter,et al. Thymic involution with ageing: obsolescence or good housekeeping? , 1996, Immunology today.
[27] P. Ruiz,et al. Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status. , 1996, Cytometry.
[28] Y. Qiu,et al. Immunoregulatory role of neurotransmitters. , 1996, Advances in Neuroimmunology.
[29] B. Malissen,et al. The cytoplasmic tail of the T cell receptor ζ chain is required for signaling via CD26 , 1995, European journal of immunology.
[30] J. Bertherat,et al. Neuroendocrine regulation of growth hormone. , 1995, European journal of endocrinology.
[31] J. Sprent,et al. T-cell apoptosis detected in situ during positive and negative selection in the thymus , 1994, Nature.
[32] W. Savino,et al. Control of thymus physiology by peptidic hormones and neuropeptides. , 1994, Immunology today.
[33] R. Gerli,et al. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule. , 1994, Cellular immunology.
[34] B. Fleischer,et al. CD26: a surface protease involved in T-cell activation. , 1994, Immunology today.
[35] G. Vanhoof,et al. Binding of adenosine deaminase to the lymphocyte surface via CD26 , 1994, European journal of immunology.
[36] Y. Bar-dayan,et al. Effect of bovine growth hormone administration on the pattern of thymic involution in mice. , 1994, Thymus.
[37] C. Morimoto,et al. Direct association of adenosine deaminase with a T cell activation antigen, CD26. , 1993, Science.
[38] V. Mukku,et al. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. , 1993, Growth regulation.
[39] J. Hadden,et al. Thymic Involution in Aging Prospects for Correction , 1992, Annals of the New York Academy of Sciences.
[40] W. Savino,et al. In vivo effects of growth hormone on thymus function in aging mice , 1992, Brain, Behavior, and Immunity.
[41] A. Globerson,et al. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow , 1992, Brain, Behavior, and Immunity.
[42] G. Plowman,et al. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells , 1992, Journal of cellular physiology.
[43] A. Globerson,et al. Patterns of dual lymphocyte development in co-cultures of foetal thymus and lymphohaemopoietic cells from young and old mice. , 1992, Immunology.
[44] E. Muñoz,et al. CD26 induces T-cell proliferation by tyrosine protein phosphorylation. , 1992, Immunology.
[45] E. Heimer,et al. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. , 1992, Biochimica et biophysica acta.
[46] K. Sakaguchi,et al. Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV). Costimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26. , 1992, Journal of immunology.
[47] B. Seed,et al. Cloning and functional expression of the T cell activation antigen CD26. , 1992, Journal of immunology.
[48] P. Chanson,et al. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. , 1992, The Journal of clinical endocrinology and metabolism.
[49] C. Caruso,et al. The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2 , 1992, Mechanisms of Ageing and Development.
[50] B. Bauvois,et al. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor‐α , 1992, European journal of immunology.
[51] D. Frasca,et al. Effect of synthetic thymic humoral factor (THF‐γ2) on T cell activities in immunodeficient ageing mice , 1992, Clinical and experimental immunology.
[52] D. Marguet,et al. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. , 1992, The Journal of biological chemistry.
[53] P. Gluckman,et al. Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I. , 1992, Growth, development, and aging : GDA.
[54] C. Morimoto,et al. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. , 1991, Journal of immunology.
[55] C. Morimoto,et al. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. , 1991, Journal of immunology.
[56] D. Marguet,et al. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV). , 1991, Journal of immunology.
[57] A. Sartorio,et al. Thymic endocrine activity in children with idiopathic growth-hormone deficiency. , 1991, The International journal of neuroscience.
[58] Toshiyuki Tanaka,et al. Molecular mechanisms underlying lymphocyte recirculation II. Differential regulation of LFA‐1 in the interaction between lymphocytes and high endothelial cells , 1991, European journal of immunology.
[59] L. Lanfrancone,et al. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody. , 1990, Cellular immunology.
[60] H. Binz,et al. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[61] N. Letvin,et al. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. , 1989, Journal of Immunology.
[62] P. Altevogt,et al. Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes , 1989, European journal of immunology.
[63] L. Frohman,et al. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. , 1989, The Journal of clinical investigation.
[64] D. Kioussis,et al. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice , 1989, Cell.
[65] H. Macdonald,et al. A novel T cell-activating molecule (THAM) highly expressed on CD4-CD8- murine thymocytes. , 1988, Journal of immunology.
[66] D. Kioussis,et al. The structure of the human CD2 gene and its expression in transgenic mice. , 1988, The EMBO journal.
[67] F. Sánchez‐Madrid,et al. Interaction between the CD45 antigen and phytohemagglutinin. Inhibitory effect on the lectininduced T cell proliferation by anti‐CD45 monoclonal antibody , 1987, European journal of immunology.
[68] E. Reinherz,et al. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. , 1984, Journal of Immunology.
[69] W. Vale,et al. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.